Based on this and our previous success with the quantitative PCR (qPCR)-based detection of EMT-associated transcription factors in CD45-depleted peripheral blood fraction of breast cancer patients [19,59,60], we tested the suitability of this approach in UM patients. This evidence concerns the gene PTPRC and breast cancer.